Rankings
▼
Calendar
CBIO Q2 2016 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena
CBIO
Crescent Biopharma, Inc.
$327M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-0.41
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$771,686
Balance Sheet
Total Assets
$56M
Total Liabilities
$7M
Stockholders' Equity
$49M
Cash & Equivalents
$53M
← FY 2016
All Quarters
Q3 2016 →
